Anagrelide Hydrochloride

CHEMBL1200759 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

292.5 g/mol

LogP

—

Phase

4

The hydrochloride salt of anagrelide that reduces platelet counts by impairing the development of platelet-producing bone marrow cells. It is prescribed for essential thrombocythemia to lower the risk of clotting complications.

Masse moléculaire

292,5000 g/mol

TPSA

44,70 Å²

Aires thérapeutiques

Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Structure 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Cl.O=C1CN2Cc3c(ccc(Cl)c3Cl)N=C2N1

InChI

InChI=1S/C10H7Cl2N3O.ClH/c11-6-1-2-7-5(9(6)12)3-15-4-8(16)14-10(15)13-7;/h1-2H,3-4H2,(H,13,14,16);1H

Molecular Formula

C10H8Cl3N3O

HBD / HBA

2 / 2

Liaisons Rotatives

0

Atomes Lourds

17

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

The hydrochloride salt of anagrelide that reduces platelet counts by impairing the development of platelet-producing bone marrow cells. It is prescribed for essential thrombocythemia to lower the risk of clotting complications.

Yes, Anagrelide Hydrochloride is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200759. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 135413494. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Anagrelide Hydrochloride sur PillFYI

Structure

Données Clés

Formule: C10H8Cl3N3O
Synonymes: 1

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.